Browse Applications
Contact Us
Probes Website

Innovative Solutions for Automated Imaging

Since 1986 MetaSystems has been designing and manufacturing systems for computerized automated microscopic imaging. From the very beginning, the close relationship to the end user has been an essential part of the MetaSystems philosophy. The following three decades have revealed that this was a successful strategy; from humble beginnings, MetaSystems has grown into a leading solution provider which still remains connected to its strong roots.

MetaSystems’ latest innovation, Neon, is a dynamic, modern imaging platform which reliably manages cases, images, and results from single workstation environments to large multi-user, multi-site installations. The Neon imaging platform ensures that all relevant information is accessible whenever needed.

Maybe you can find a solution to your imaging automation problem here on this web site. We recommend starting your journey on the application pages, if you are not familiar with our product portfolio. In case you are, it may be easier to go directly to the page for the product you actually look for. Should you feel lost, please feel free to contact us or the MetaSystems partner in your country.

We believe in communication being the first step towards innovative solutions!

Aneuploid CTC and CEC

Circulating tumor cells (CTCs) are cancer cells shed from primary or metastatic solid tumors into peripheral blood, whereas circulating endothelial cells (CECs) are derived from endothelial cells (ECs) of blood vessels into circulation. Clinical relevance of CTCs in tumor metastasis and prognosis [...], CECs in tumor angiogenesis [...], and CEC clusters in carcinoma [...] have been substantially discussed elsewhere. [...] Detection of circulating rare cells (CRCs), including both CTCs and CECs, is the most representative of liquid biopsy due to its unique availability of frequent and non-invasive detecting tumor cells in carcinoma patients. [...] Somatic aneuploidy is the most common characteristic of human carcinomas [...]. Approximately 90% of solid tumors and 75% of hematological carcinomas exhibit aneuploidy [...]. In particular, aneuploid chromosome 8 (Chr 8) was observed in neoplasm cells of several solid tumors, including lung, gastric, pancreatic, colon, bladder, esophageal, and hepatocellular carcinomas, etc. [...]. [...] The established SE-iFISH strategy, facilitated by the newly developed Metafer-iFISH [...] automated CRC image scanning and analysis system [...], provides a unique comprehensive platform to effectively detect, phenotypically and karyotypically characterize CRCs with cytogenetic abnormalities of chromosome aneuploidy or gene rearrangements (such as ALK gene) in situ, in both patients and PDX tumor animal models.

Cited From: Diagnostics (Basel, Switzerland) (2018) Read more...
All Publications

Related Products/Solutions

Assistance Required?

Please do not hesitate to contact us.

Phone
Email
By Country
Web Form

Are You Looking for Probes?

MetaSystems Probes now has its own website. If you are looking for MetaSystems XCyting DNA Probes, please visit the MetaSystems Probes website.

Next Event

Annual Meeting of the German Society for Human Genetics (GfH)

Upcoming Event in Germany from Mar 16 to Mar 18, 2022

Link to Event Website

The German Society of Human Genetics, formerly the "Society of Anthropology and Human Genetics", was founded in 1987. Its principal objective is the promotion of research, education and practicing in all areas of human genetics. The society organizes scientific meetings, conferences and workshops to share and discuss scientific progress. In addition, the society encourages and integrates different scientific and clinical specialties of human genetics.

More Events

Latest News

Power Up.

35 Years of MetaSystems
Year 22: 2007

Power Up.
All News